Fibrosis Clinical Trials in Seattle, Washington
30 recruitingSeattle, Washington
Showing 1–20 of 30 trials
Recruiting
Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
Boehringer Ingelheim1,700 enrolled371 locationsNCT06238622
Recruiting
Phase 2
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Primary MyelofibrosisMyelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
GlaxoSmithKline68 enrolled33 locationsNCT06517875
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
MASH With FibrosisNASH With Fibrosis
Akero Therapeutics, Inc1,650 enrolled349 locationsNCT06215716
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
LymphomaMyelofibrosisAML (Acute Myelogenous Leukemia)+8 more
Center for International Blood and Marrow Transplant Research358 enrolled13 locationsNCT06859424
Recruiting
Phase 2
Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Acute Myeloid LeukemiaMyelodysplastic SyndromeMyeloproliferative Neoplasm+6 more
University of Washington25 enrolled1 locationNCT04282187
Recruiting
Phase 2
4D-710 in Adult Patients With Cystic Fibrosis
Cystic Fibrosis Lung
4D Molecular Therapeutics30 enrolled20 locationsNCT05248230
Recruiting
Not Applicable
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
Cystic Fibrosis
University of Washington, the Collaborative Health Studies Coordinating Center430 enrolled33 locationsNCT06654752
Recruiting
Phase 2
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Myelodysplastic/Myeloproliferative NeoplasmPrimary MyelofibrosisSecondary Myelofibrosis
Fred Hutchinson Cancer Center50 enrolled1 locationNCT07228624
Recruiting
Phase 2
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Primary MyelofibrosisSecondary Myelofibrosis
Fred Hutchinson Cancer Center20 enrolled1 locationNCT04370301
Recruiting
Phase 1
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
Myelofibrosis
Geron Corporation36 enrolled8 locationsNCT05371964
Recruiting
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Cystic FibrosisParenthood Status
University of Pittsburgh146 enrolled18 locationsNCT06296394
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Cystic Fibrosis
Boston Children's Hospital200 enrolled18 locationsNCT06683092
Recruiting
Phase 2
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Cystic FibrosisCFTR Gene Mutation
Arcturus Therapeutics, Inc.12 enrolled11 locationsNCT06747858
Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
Nicole Hamblett400 enrolled68 locationsNCT06504589
Recruiting
Phase 4
Ensuring Access to Optimal Therapy in CF: The ENACT Study
Cystic Fibrosis (CF)
Arkansas Children's Hospital Research Institute95 enrolled2 locationsNCT07148739
Recruiting
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
Cystic Fibrosis (CF)
State University of New York at Buffalo600 enrolled13 locationsNCT07048574
Recruiting
Phase 1
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
Castrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic Leukemia+1 more
Epigenetix, Inc.75 enrolled6 locationsNCT05488548
Recruiting
Not Applicable
Lung Transplant READY CF 2: CARING CF Ancillary RCT
Cystic Fibrosis
University of Washington132 enrolled1 locationNCT06032273
Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Cystic Fibrosis
Sonya Heltshe210 enrolled35 locationsNCT04509050